Company Filing History:
Years Active: 2017
Title: Holger Bittermann: Innovator in Antibody Purification Technologies
Introduction
Holger Bittermann is a notable inventor based in Schriesheim, Germany. He has made significant contributions to the field of biochemistry, particularly in the area of antibody purification. His innovative work has led to the development of a patented technology that enhances the efficiency of antibody purification processes.
Latest Patents
Holger Bittermann holds a patent titled "Ligands for antibody and Fc-fusion protein purification by affinity chromatography IV." This invention relates to the use of a ligand-substituted matrix for the affinity purification of antibodies or their fragments. The matrix comprises a support material and at least one ligand covalently bonded to it, represented by a specific formula. This advancement is crucial for improving the purification processes in biopharmaceutical applications.
Career Highlights
Throughout his career, Holger Bittermann has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Novalix Deutschland GmbH and Graffinity Pharmaceuticals GmbH. His experience in these organizations has allowed him to refine his expertise in antibody purification technologies.
Collaborations
Holger Bittermann has collaborated with several professionals in his field, including Marc Arnold and Thomas Neumann. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Holger Bittermann's contributions to antibody purification technologies exemplify the impact of innovative thinking in the biotechnology sector. His patent and career achievements highlight his role as a significant inventor in this field.